Home/Filings/4/0001628280-25-009628
4//SEC Filing

Odence-Ford Marion 4

Accession 0001628280-25-009628

CIK 0001448431other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 9:16 AM ET

Size

8.9 KB

Accession

0001628280-25-009628

Insider Transaction Report

Form 4
Period: 2025-03-01
Odence-Ford Marion
Chief Legal Officer & CHRO
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-017710 total
    Common Stock (771 underlying)
  • Tax Payment

    Common Stock

    2025-03-01$5.18/sh268$1,38870,276 total
  • Exercise/Conversion

    Common Stock

    2025-03-01+77170,544 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
  • [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
  • [F3]The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001845002

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:16 AM ET
Size
8.9 KB